Pharmacokinetic Dashboard-Recommended Dosing Is Different than Standard of Care Dosing in Infliximab-Treated Pediatric IBD Patients

2016 ◽  
Vol 19 (1) ◽  
pp. 215-222 ◽  
Author(s):  
Marla C. Dubinsky ◽  
Becky L. Phan ◽  
Namita Singh ◽  
Shervin Rabizadeh ◽  
Diane R. Mould
Keyword(s):  
Standard Of Care ◽  
Pediatric Ibd

scholarly journals Telemedicine and Integrated Multidisciplinary Care for Pediatric IBD Patients: A Review

Children ◽  
2021 ◽  
Vol 8 (5) ◽  
pp. 347
Author(s):  
Lauren M. Potthoff
Keyword(s):  
Multidisciplinary Treatment ◽  
Multidisciplinary Care ◽  
Standard Of Care ◽  
Future Research ◽  
Global Pandemic ◽  
Inflammatory Bowel ◽  
Virtual Platform ◽  
One Year ◽  
The One ◽  
Pediatric Ibd

The global COVID-19 pandemic brought with it an unprecedented, widespread implementation of telemedicine services, requiring pediatric inflammatory bowel disease (IBD) providers to shift in-person clinic visits to a virtual platform. With the passing of the one-year anniversary of the global pandemic, telemedicine continues to be offered and utilized. Although it remains unclear as to the extent to which telemedicine services will be used in the future, it is critical to understand how integrated multidisciplinary treatment—the standard of care in pediatric IBD—is delivered through a virtual platform. This paper provides an overview of the existing literature examining integrated multidisciplinary care for pediatric IBD provided via telemedicine. The author also presents one integrated multidisciplinary IBD program’s response to the global pandemic and subsequent transition to telemedicine. Challenges around implementation and directions for future research in this area are also discussed.

231: Laparoscopic Nephrectomy: Prolonged Diffusion of a Standard of Care

2006 ◽  
Vol 175 (4S) ◽  
pp. 77-77
Author(s):  
David C. Miller ◽  
John T. Wei ◽  
Brent K. Hollenbeck
Keyword(s):  
Standard Of Care ◽  
Laparoscopic Nephrectomy

26: Cost Trends for Oncologic Renal Surgery: Support for a Laparoscopic Standard of Care

2005 ◽  
Vol 173 (4S) ◽  
pp. 8-8
Author(s):  
John M. Hollingsworth ◽  
David C. Miller ◽  
J. Stuart Wolf
Keyword(s):  
Standard Of Care ◽  
Renal Surgery

Which Standard of Care?

2010 ◽  
Vol 40 (7) ◽  
pp. 52
Author(s):  
S.Y. TAN
Keyword(s):  
Standard Of Care

Could alcohol ablation become the standard of care for benign insulinomas?

2017 ◽  
Author(s):  
Isabel Mazarico ◽  
David Subias ◽  
Felix Junquera ◽  
Carme Vilardell ◽  
Ignasi Saigi ◽  
...  
Keyword(s):  
Standard Of Care ◽  
Alcohol Ablation

Percutaneous Mitral Annuloplasty for Treatment of Functional Mitral Regurgitation

2009 ◽  
Vol 5 (1) ◽  
pp. 67
Author(s):  
Lutz Buellesfeld ◽  
Lazar Mandinov ◽  
Eberhard Grube ◽  
◽  
◽  
...  
Keyword(s):  
Mitral Regurgitation ◽  
Coronary Sinus ◽  
Standard Of Care ◽  
Mitral Annulus ◽  
Functional Mitral Regurgitation ◽  
Invasive Treatment ◽  
Large Variability ◽  
Mitral Annuloplasty ◽  
Number Of Patients ◽  
Anatomical Relationship

Functional mitral regurgitation affects a substantial proportion of patients with congestive heart failure due to myocardial infarction or dilated cardiomyopathy. Functional mitral regurgitation greatly increases morbidity and mortality. Surgical annuloplasty is the standard of care for symptomatic patients with moderate or severe functional mitral regurgitation; however, a large number of patients are refused surgery. Several percutaneous approaches have been developed to address the need for less invasive treatment of mitral annulus dilatation. Devices using coronary sinus to cinch the mitral annulus are relatively easy to use; however, a number of factors may limit their clinical application, such as suboptimal anatomical relationship between the coronary sinus and mitral annulus, risk of coronary artery compression, large variability in the coronary venous anatomy and conflict with other therapies such as ablation or cardiac resynchronisation. Direct mitral annuloplasty is anticipated to be more effective than the coronary sinus approaches; however, it has yet to prove its safety and efficacy in carefully designed clinical trials. The best candidates and the best timing for each percutaneous mitral annuloplasty therapy, whether direct or indirect, have yet to be identified.

EFFICACY OF A NOVEL DEVICE TO DETECT, ALERT AND RESOLVE NEONATAL APNEA - PILOT STUDY

2019 ◽  
Vol 9 (9) ◽  
pp. 608-613
Author(s):  
Dr. Swapna Lingaldinna,Dr. Himabindu Singh,Mona Sharma*
Keyword(s):  
Newborn Care ◽  
Standard Of Care ◽  
The Novel ◽  
Tertiary Referral ◽  
Tertiary Referral Hospital ◽  
Care Community ◽  
Novel Device ◽  
Sick Newborn ◽  
Central Apneas ◽  
Neonatal Apnea

Objective: To measure the accuracy of a novel device in detecting Bradycardia andDesaturation (B&D) events and to determine its efficacy in resolving apneas innewborns with comparison to standard monitor (which only detects B&D eventsand alerts).Design: This was a prospective observational study.Setting: Sick Newborn Care Unit of a large tertiary referral hospital in Hyderabad,India.Methods: 31 newborns were provided with a novel device, which monitored oxygensaturation and pulse rate and alarmed when values dropped below a set thresholdwhich is referred as an event, henceforth. The novel device also provided footstimulation in response to above-mentioned events. When the monitor alarmed, anurse attended to the baby to confirm whether the baby was breathing and whetherthe event had been resolved by the device. If the event had not resolved, appropriateaction as per the standard-of-care was performed.Results: The novel device “ApneBootTM” positively detected B&D events 94.03% oftimes as compared to the standard reference monitor. 56 of 67 observed B&D eventswere visually confirmed to be apneas, indicating that 83.6% of B&D eventscoincided with apneas. Of the 56 apneic events, 50 were central apneas, of which 35were resolved by the novel device, making the device’s efficacy of apnea resolution70%.Conclusion: The results of the study indicate that this novel device “ApneBootTM”is very effective in detecting and alarming B&D events, which coincides with theapnea, and resolving it by providing foot stimulation.Keywords: Novel Device, Neonatal Apnea, Low Birth Weight, Body Temperature,Kangaroo Mother Care, Community Health,

Sign in / Sign up

Export Citation Format

Share Document